House & Home
Christopher Marai Downgraded (BIIB) to Hold and Decreased Target to $378 on, Jan 5th, 2015
Christopher Marai of Nomura, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $407 to $378 on, Jan 5th, 2015.
Christopher has made no other calls on BIIB in the last 4 months.
There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Christopher
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $400 on, Wednesday, November 19th, 2014
- Brian Skorney of "Baird" Upgraded from Hold to Buy on, Wednesday, October 22nd, 2014
Similar House and Home Articles
[ Wed, Nov 19th 2014
] - WOPRAI
[ Thu, May 29th 2014
] - WOPRAI
[ Thu, Apr 24th 2014
] - WOPRAI
[ Fri, Feb 14th 2014
] - WOPRAI
[ Tue, Jan 28th 2014
] - WOPRAI
[ Fri, Jan 24th 2014
] - WOPRAI
[ Wed, Jan 08th 2014
] - WOPRAI
[ Mon, Apr 22nd 2013
] - WOPRAI
[ Tue, Apr 09th 2013
] - WOPRAI
[ Mon, Mar 25th 2013
] - WOPRAI
[ Thu, Jan 03rd 2013
] - WOPRAI